{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:11:48Z","timestamp":1769076708278,"version":"3.49.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170965"],"award-info":[{"award-number":["82170965"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270983"],"award-info":[{"award-number":["82270983"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.intimp.2024.112122","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:03:30Z","timestamp":1713985410000},"page":"112122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Implications of innate lymphoid cells in oral diseases"],"prefix":"10.1016","volume":"133","author":[{"given":"Si-Ting","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-7638","authenticated-orcid":false,"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2013a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"6237","key":"10.1016\/j.intimp.2024.112122_b0010","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/imm.13599","article-title":"Helper innate lymphoid cells as cell therapy for cancer","volume":"168","author":"Magnusson","year":"2023","journal-title":"Immunology"},{"issue":"7534","key":"10.1016\/j.intimp.2024.112122_b0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8091342","article-title":"Innate lymphoid cells: important regulators of host-bacteria interaction for border defense","volume":"8","author":"Beck","year":"2020","journal-title":"Microorganisms"},{"issue":"43","key":"10.1016\/j.intimp.2024.112122_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aau4594","article-title":"Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity","volume":"5","author":"Gaffen","year":"2020","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-023-00562-w","article-title":"Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity","author":"Ruf","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41232-023-00272-8","article-title":"Group 2 innate lymphoid cells and their surrounding environment","volume":"43","author":"Naito","year":"2023","journal-title":"Inflamm Regen"},{"issue":"7","key":"10.1016\/j.intimp.2024.112122_b0055","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20222005","article-title":"TIGIT mediates activation-induced cell death of ILC2s during chronic airway allergy","volume":"220","author":"Yamada","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112122_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101284","article-title":"ILC regulation of T cell responses in inflammatory diseases and cancer","volume":"41","author":"Warner","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100963","article-title":"ILC in chronic inflammation, cancer and targeting with biologicals","volume":"80","author":"De Pasquale","year":"2021","journal-title":"Mol. Aspects Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41590-022-01127-z","article-title":"Innate lymphoid cells and cancer","volume":"23","author":"Jacquelot","year":"2022","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0075","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/froh.2022.851786","article-title":"The role of the oral immune system in oropharyngeal candidiasis-facilitated invasion and dissemination of staphylococcus aureus","volume":"3","author":"Pasman","year":"2022","journal-title":"Front Oral Health"},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0085","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/infdis\/jit574","article-title":"Human natural killer cells acting as phagocytes against candida albicans and mounting an inflammatory response that modulates neutrophil antifungal activity","volume":"209","author":"Voigt","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0090","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/s41467-022-30087-z","article-title":"Candida albicans evades NK cell elimination via binding of agglutinin-like sequence proteins to the checkpoint receptor TIGIT","volume":"13","author":"Charpak-Amikam","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0095","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2022.09.022","article-title":"Human natural killer cells: form, function, and development","volume":"151","author":"Mace","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101709","article-title":"Natural killer cells and type 1 innate lymphoid cells in cancer","volume":"66","author":"Lopes","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2014.00282","article-title":"Beyond NK cells: the expanding universe of innate lymphoid cells","volume":"5","author":"Cella","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0110","article-title":"To kill or not to kill - the role of the tumor microenvironment in shaping group 1 ILC functions","volume":"61\u201364","author":"M\u00fcller","year":"2022","journal-title":"Semin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112122_b0115","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ijc.34389","article-title":"The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity","volume":"152","author":"Tumino","year":"2023","journal-title":"Int. J. Cancer"},{"issue":"415","key":"10.1016\/j.intimp.2024.112122_b0120","doi-asserted-by":"crossref","first-page":"ra19","DOI":"10.1126\/scisignal.aad1884","article-title":"TGF-\u03b2 inhibits the activation and functions of NK cells by repressing the mTOR pathway","volume":"9","author":"Viel","year":"2016","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2024.112122_b0125","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","article-title":"Influence of the tumor microenvironment on NK Cell function in solid tumors","volume":"10","author":"Melaiu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215925","article-title":"TGF-\u03b2 signaling networks in the tumor microenvironment","volume":"550","author":"Chan","year":"2022","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0135","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ni.3809","article-title":"SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-\u03b2 signaling","volume":"18","author":"Cortez","year":"2017","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0140","doi-asserted-by":"crossref","first-page":"e2149435","DOI":"10.1002\/eji.202149435","article-title":"ILC1: development, maturation, and transcriptional regulation","volume":"53","author":"Taggenbrock","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.trecan.2022.10.007","article-title":"Innate lymphoid cells: potential targets for cancer therapeutics","volume":"9","author":"Ng","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.intimp.2024.112122_b0160","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3389\/fimmu.2020.01190","article-title":"eomes expression defines group 1 innate lymphoid cells during metastasis in human and mouse","volume":"11","author":"Verma","year":"2020","journal-title":"Front. Immunol."},{"issue":"70","key":"10.1016\/j.intimp.2024.112122_b0165","doi-asserted-by":"crossref","first-page":"eabi8642","DOI":"10.1126\/sciimmunol.abi8642","article-title":"Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity","volume":"7","author":"Nixon","year":"2022","journal-title":"Sci. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.immuni.2020.12.004","article-title":"Group 1 innate lymphoid-cell-derived interferon-\u03b3 maintains anti-viral vigilance in the mucosal epithelium","volume":"54","author":"Shannon","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0175","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 confer early host protection at initial sites of viral infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.immuni.2021.01.002","article-title":"ILC1: guardians of the oral mucosa against enemy viruses","volume":"54","author":"Nabekura","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0185","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jaci.2019.09.001","article-title":"TNF induces production of type 2 cytokines in human group 2 innate lymphoid cells","volume":"145","author":"Ogasawara","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041350","article-title":"Group 2 innate lymphoid cells: central players in a recurring theme of repair and regeneration","volume":"21","author":"Messing","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0195","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0200","doi-asserted-by":"crossref","first-page":"1244437","DOI":"10.3389\/fimmu.2023.1244437","article-title":"The IL-25\/ILC2 axis promotes lung cancer with a concomitant accumulation of immune-suppressive cells in tumors in humans and mice","volume":"14","author":"Bahhar","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112122_b0205","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.40500","article-title":"Interleukin-25 axis is involved in the pathogenesis of human primary and experimental murine sj\u00f6gren's syndrome","volume":"70","author":"Guggino","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2020.02.009","article-title":"Interleukin-33 induces the enzyme tryptophan hydroxylase 1 to promote inflammatory group 2 innate lymphoid cell-mediated immunity","volume":"52","author":"Flamar","year":"2020","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.intimp.2024.112122_b0215","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/s41423-021-00765-x","article-title":"Group 2 innate lymphoid cells can engulf and destroy bacteria","volume":"18","author":"Yang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jss.2016.06.081","article-title":"Innate lymphoid cells: a paradigm for low SSI in cleft lip repair","volume":"205","author":"Simmerman","year":"2016","journal-title":"J. Surg. Res."},{"issue":"10","key":"10.1016\/j.intimp.2024.112122_b0225","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.trecan.2022.06.010","article-title":"Cancer immunosurveillance by ILC2s","volume":"8","author":"Wagner","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.intimp.2024.112122_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.04.004","article-title":"The pro- and anti-tumor role of ILC2s","volume":"41","author":"Trabanelli","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0235","article-title":"Role of ILC2s in solid tumors: facilitate or inhibit?","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112122_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113452","article-title":"Group 2 innate lymphoid cells: a double-edged sword in cancer?","volume":"12","author":"Maggi","year":"2020","journal-title":"Cancers (basel)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0245","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1038\/s41467-021-22764-2","article-title":"PPAR\u0263 drives IL-33-dependent ILC2 pro-tumoral functions","volume":"12","author":"Ercolano","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2024.112122_b0250","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.4049\/jimmunol.1800173","article-title":"Type 2 innate lymphoid cells impede IL-33-mediated tumor suppression","volume":"201","author":"Long","year":"2018","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0255","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/imm.12697","article-title":"Functional and phenotypic heterogeneity of group 3 innate lymphoid cells","volume":"150","author":"Melo-Gonzalez","year":"2017","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1084\/jem.20131038","article-title":"Gata3 drives development of ROR\u03b3t+ group 3 innate lymphoid cells","volume":"211","author":"Serafini","year":"2014","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.intimp.2024.112122_b0265","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/s41590-019-0423-0","article-title":"c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies","volume":"20","author":"Bernink","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0270","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4049\/jimmunol.1202924","article-title":"Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection","volume":"190","author":"Gladiator","year":"2013","journal-title":"J. Immunol."},{"issue":"6178","key":"10.1016\/j.intimp.2024.112122_b0275","doi-asserted-by":"crossref","first-page":"1249288","DOI":"10.1126\/science.1249288","article-title":"Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis","volume":"343","author":"Mortha","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0280","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12931-023-02395-5","article-title":"Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation","volume":"24","author":"He","year":"2023","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2024.112122_b0285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: immunobiology and pathology","volume":"33","author":"Dudakov","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112122_b0290","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","article-title":"IL-17 receptor-based signaling and implications for disease","volume":"20","author":"Li","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.742571","article-title":"Human ILC3 exert TRAIL-mediated cytotoxicity towards cancer cells","volume":"13","author":"Siegler","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0300","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41590-021-01120-y","article-title":"Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses","volume":"23","author":"Bruchard","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0305","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13189","article-title":"Layered origins of lymphoid tissue inducer cells","author":"van de Pavert","year":"2023","journal-title":"Immunol. Rev."},{"issue":"23","key":"10.1016\/j.intimp.2024.112122_b0310","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101668118","article-title":"Spatial distribution of LTi-like cells in intestinal mucosa regulates type 3 innate immunity","volume":"118","author":"S\u00e9cca","year":"2021","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0315","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bj.2020.12.003","article-title":"Lymphoid Tissue inducer (LTi) cell ontogeny and functioning in embryo and adult","volume":"44","author":"van de Pavert","year":"2021","journal-title":"Biomed J"},{"issue":"11","key":"10.1016\/j.intimp.2024.112122_b0320","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1084\/jem.20180217","article-title":"Multiple roles of lymphatic vessels in peripheral lymph node development","volume":"215","author":"Bovay","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2024.112122_b0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cytogfr.2018.02.004","article-title":"Lymphoid tissue inducer-a divergent member of the ILC family","volume":"42","author":"Zhong","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2024.112122_b0330","doi-asserted-by":"crossref","DOI":"10.1007\/s11010-023-04699-y","article-title":"Lymphoid tissue inducer cells in cancer: a potential therapeutic target","author":"Singh","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2024.112122_b0335","article-title":"Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma","author":"Liu","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.intimp.2024.112122_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2023.03.023","article-title":"Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice","author":"LeSuer","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7937","key":"10.1016\/j.intimp.2024.112122_b0345","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41586-022-05395-5","article-title":"Non-redundant functions of group 2 innate lymphoid cells","volume":"611","author":"Jarick","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2024.112122_b0350","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/intimm\/dxac019","article-title":"Epidermal clearance of candida albicans is mediated by IL-17 but independent of fungal innate immune receptors","volume":"34","author":"Iwasawa","year":"2022","journal-title":"Int. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112122_b0355","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41577-019-0194-8","article-title":"Functional interactions between innate lymphoid cells and adaptive immunity","volume":"19","author":"Sonnenberg","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112122_b0360","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/s41423-021-00689-6","article-title":"Dynamic regulation of innate lymphoid cells in the mucosal immune system","volume":"18","author":"Shao","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0365","article-title":"The role of ILC subsets in cancer","volume":"61\u201364","author":"Bruchard","year":"2022","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0370","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12935-023-02943-5","article-title":"Targeting oral tumor microenvironment for effective therapy","volume":"23","author":"Budi","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0375","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005061","article-title":"N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor","volume":"10","author":"Lou","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"17","key":"10.1016\/j.intimp.2024.112122_b0380","doi-asserted-by":"crossref","first-page":"e89829","DOI":"10.1172\/jci.insight.89829","article-title":"The head and neck cancer immune landscape and its immunotherapeutic implications","volume":"1","author":"Mandal","year":"2016","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0385","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jop.13357","article-title":"Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma","volume":"52","author":"Huang","year":"2023","journal-title":"J. Oral Pathol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0390","doi-asserted-by":"crossref","first-page":"1747345","DOI":"10.1080\/2162402X.2020.1747345","article-title":"The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis","volume":"9","author":"Bisheshar","year":"2020","journal-title":"Oncoimmunology"},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0395","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092268","article-title":"Prognostic potential of tumor-infiltrating immune cells in resectable oral squamous cell carcinoma","volume":"13","author":"Caruntu","year":"2021","journal-title":"Cancers (basel)"},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0400","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/j.oraloncology.2010.02.019","article-title":"Evaluation of natural killer cell defense in oral squamous cell carcinoma","volume":"46","author":"T\u00fcrkseven","year":"2010","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0405","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cyto.2015.09.006","article-title":"Negative regulation of natural killer cell in tumor tissue and peripheral blood of oral squamous cell carcinoma","volume":"76","author":"Dutta","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0410","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imcb.12602","article-title":"Downregulation of AT-rich interaction domain 2 underlies natural killer cell dysfunction in oral squamous cell carcinoma","volume":"101","author":"Li","year":"2023","journal-title":"Immunol. Cell Biol."},{"issue":"28","key":"10.1016\/j.intimp.2024.112122_b0415","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101169118","article-title":"Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment","volume":"118","author":"Moreno-Nieves","year":"2021","journal-title":"PNAS"},{"issue":"33","key":"10.1016\/j.intimp.2024.112122_b0420","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110875118","article-title":"Intraepithelial ILC1-like cells: Front-line fighters in human head and neck squamous cell carcinoma","volume":"118","author":"Cella","year":"2021","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0425","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021627","article-title":"Differential regulation of innate lymphoid cells in human and murine oral squamous cell carcinoma","volume":"24","author":"Syed","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0435","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190297","article-title":"The role of interleukin-17 in tumor development and progression","volume":"217","author":"Zhao","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0440","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jdsr.2019.09.001","article-title":"Immunomodulatory aspects in the progression and treatment of oral malignancy","volume":"55","author":"Kondoh","year":"2019","journal-title":"Jpn Dent Sci Rev"},{"key":"10.1016\/j.intimp.2024.112122_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110094","article-title":"Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway","volume":"118","author":"Li","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0450","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4110\/in.2020.20.e6","article-title":"IL-17-producing cells in tumor immunity: friends or foes?","volume":"20","author":"Kuen","year":"2020","journal-title":"Immune Netw"},{"issue":"6576","key":"10.1016\/j.intimp.2024.112122_b0455","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.intimp.2024.112122_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15123227","article-title":"The distinctive features behind the aggressiveness of oral and cutaneous squamous cell carcinomas","volume":"15","author":"Alonso-Juarranz","year":"2023","journal-title":"Cancers (basel)"},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0465","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0470","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.803563","article-title":"The role of innate lymphoid cells in cancer development and immunotherapy","volume":"10","author":"Sugimura","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112122_b0475","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41568-022-00491-0","article-title":"Natural killer cells in antitumour adoptive cell immunotherapy","volume":"22","author":"Laskowski","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.intimp.2024.112122_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.04.002","article-title":"Helper-like innate lymphoid cells and cancer immunotherapy","volume":"41","author":"Crinier","year":"2019","journal-title":"Semin. Immunol."},{"issue":"29","key":"10.1016\/j.intimp.2024.112122_b0485","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1200\/JCO.2015.61.1509","article-title":"Immunology and immunotherapy of head and neck cancer","volume":"33","author":"Ferris","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0490","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12016-020-08793-7","article-title":"Immunobiology of T cells in sj\u00f6gren's syndrome","volume":"60","author":"Yao","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2024.112122_b0495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063090","article-title":"Role of the Innate immunity signaling pathway in the pathogenesis of sj\u00f6gren's syndrome","volume":"22","author":"Shimizu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.intimp.2024.112122_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239172","article-title":"Innate immunity and biological therapies for the treatment of sj\u00f6gren's syndrome","volume":"21","author":"Srivastava","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0505","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrrheum.2013.110","article-title":"Advances in understanding the pathogenesis of primary Sj\u00f6gren's syndrome","volume":"9","author":"Nocturne","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.112122_b0510","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren's syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0515","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020658","article-title":"The involvement of innate and adaptive immunity in the initiation and perpetuation of sj\u00f6gren's syndrome","volume":"22","author":"Chivasso","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0520","article-title":"Primary Sjogren syndrome: focus on innate immune cells and inflammation","volume":"8","author":"Rizzo","year":"2020","journal-title":"Vaccines (basel)"},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0525","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9093057","article-title":"Contributions of major cell populations to sj\u00f6gren's syndrome","volume":"9","author":"Witas","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2024.112122_b0530","doi-asserted-by":"crossref","first-page":"1036787","DOI":"10.3389\/fmed.2022.1036787","article-title":"Disturbed natural killer cell homeostasis in the salivary gland enhances autoimmune pathology via IFN-\u03b3 in a mouse model of primary sj\u00f6gren's syndrome","volume":"9","author":"Sato","year":"2022","journal-title":"Front Med (lausanne)"},{"issue":"195","key":"10.1016\/j.intimp.2024.112122_b0535","doi-asserted-by":"crossref","first-page":"195ra96","DOI":"10.1126\/scitranslmed.3005727","article-title":"NCR3\/NKp30 contributes to pathogenesis in primary Sjogren's syndrome","volume":"5","author":"Rusakiewicz","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.112122_b0540","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.706737","article-title":"NKp30 receptor upregulation in salivary glands of Sj\u00f6gren's syndrome characterizes ectopic lymphoid structures and is restricted by rituximab treatment","volume":"12","author":"Pontarini","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112122_b0545","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj\u00f6gren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0550","doi-asserted-by":"crossref","first-page":"e18003","DOI":"10.1371\/journal.pone.0018003","article-title":"Location of immunization and interferon-\u03b3 are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sj\u00f6gren's syndrome","volume":"6","author":"Yin","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2024.112122_b0555","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/rheumatology\/kez116","article-title":"Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"58","author":"Blokland","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0560","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003051","article-title":"Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sj\u00f6gren's syndrome","volume":"9","author":"Kawka","year":"2023","journal-title":"RMD Open"},{"issue":"24","key":"10.1016\/j.intimp.2024.112122_b0565","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1073\/pnas.1005641107","article-title":"Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity","volume":"107","author":"Cella","year":"2010","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0570","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.2830","article-title":"Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells","volume":"15","author":"Magri","year":"2014","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.112122_b0575","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41423-023-01041-w","article-title":"Reciprocal costimulatory molecules control the activation of mucosal type 3 innate lymphoid cells during engagement with B cells","volume":"20","author":"Lv","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0580","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/prd.12221","article-title":"Periodontitis: facts, fallacies and the future","volume":"75","author":"Slots","year":"2017","journal-title":"Periodontol 2000"},{"issue":"7","key":"10.1016\/j.intimp.2024.112122_b0585","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076099","article-title":"Function of innate lymphoid cells in periodontal tissue homeostasis: a narrative review","volume":"24","author":"Ma","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"24","key":"10.1016\/j.intimp.2024.112122_b0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249766","article-title":"Influence of natural killer cells and natural killer T cells on periodontal disease: a systematic review of the current literature","volume":"21","author":"Seidel","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2024.112122_b0595","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1177\/0022034518782141","article-title":"Enrichment of innate lymphoid cell populations in gingival tissue","volume":"97","author":"Brown","year":"2018","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.intimp.2024.112122_b0600","article-title":"ILC1s and ILC3s exhibit inflammatory phenotype in periodontal ligament of periodontitis patients","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0605","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/mi.2015.136","article-title":"Characterization of the human immune cell network at the gingival barrier","volume":"9","author":"Dutzan","year":"2016","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0610","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/JPER.17-0750","article-title":"Innate lymphoid cells are present in gingivitis and periodontitis","volume":"90","author":"Kindstedt","year":"2019","journal-title":"J. Periodontol"},{"key":"10.1016\/j.intimp.2024.112122_b0615","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3389\/fimmu.2017.00922","article-title":"Increased innate lymphoid cells in periodontal tissue of the murine model of periodontitis: the role of AMP-activated protein kinase and relevance for the human condition","volume":"8","author":"Qin","year":"2017","journal-title":"Front. Immunol."},{"issue":"229","key":"10.1016\/j.intimp.2024.112122_b0620","doi-asserted-by":"crossref","first-page":"229ra40","DOI":"10.1126\/scitranslmed.3007696","article-title":"Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss","volume":"6","author":"Moutsopoulos","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0625","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0030-4220(72)90467-7","article-title":"Lichen planus as an oral ulcerative disease","volume":"33","author":"Shklar","year":"1972","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0630","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/prd.12260","article-title":"Oral lichen planus: a disease or a spectrum of tissue reactions? types, causes, diagnostic algorhythms, prognosis, management strategies","volume":"80","author":"Carrozzo","year":"2019","journal-title":"Periodontol 2000"},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0635","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/jdv.13989","article-title":"Distinct interferon-gamma and interleukin-9 expression in cutaneous and oral lichen planus","volume":"31","author":"Weber","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112122_b0640","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15113004","article-title":"Risk of oral squamous cell carcinoma in one hundred patients with oral lichen planus: a follow-up study of umberto i university hospital of rome","volume":"15","author":"Tenore","year":"2023","journal-title":"Cancers (basel)"},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jop.12142","article-title":"Inflammation-related cytokines in oral lichen planus: an overview","volume":"44","author":"Lu","year":"2015","journal-title":"J. Oral Pathol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0650","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0714.2003.00077.x","article-title":"Th1 cytokines in oral lichen planus","volume":"32","author":"Khan","year":"2003","journal-title":"J. Oral Pathol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0655","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1007\/s10753-015-0167-4","article-title":"A study of association between oral lichen planus and immune balance of Th1\/Th2 cells","volume":"38","author":"Wang","year":"2015","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0660","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jds.2022.08.032","article-title":"Association of polymorphisms in Th1\/Th2-related cytokines (IFN-\u03b3, TGF\u03b21, IL-1\u03b2, IL-2, IL-4, IL-18) with oral lichen planus: A pooled analysis of case-control studies","volume":"18","author":"Liu","year":"2023","journal-title":"J Dent Sci"},{"key":"10.1016\/j.intimp.2024.112122_b0665","article-title":"The tipped balance of ILC1\/ILC2 in peripheral blood of oral lichen planus is related to inflammatory cytokines","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0670","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/154411130201300405","article-title":"The pathogenesis of oral lichen planus","volume":"13","author":"Sugerman","year":"2002","journal-title":"Crit. Rev. Oral Biol. Med."},{"key":"10.1016\/j.intimp.2024.112122_b0675","doi-asserted-by":"crossref","first-page":"1023213","DOI":"10.3389\/fimmu.2022.1023213","article-title":"Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment","volume":"13","author":"Deng","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0680","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24033038","article-title":"Comprehensive insight into lichen planus immunopathogenesis","volume":"24","author":"Vi\u010di\u0107","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0685","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.0022-202X.2003.22108.x","article-title":"Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus","volume":"122","author":"Carrozzo","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2024.112122_b0690","article-title":"Group 1 and 3 innate lymphoid cells are increased in oral lichen planus and oral lichenoid lesions","author":"Pan","year":"2022","journal-title":"Oral Dis."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0695","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen","volume":"49","author":"Kim","year":"2011","journal-title":"J. Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112122_b0700","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8091340","article-title":"Recognition of candida albicans and role of innate type 17 immunity in oral candidiasis","volume":"8","author":"Pavlova","year":"2020","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.intimp.2024.112122_b0705","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chom.2016.10.001","article-title":"IL-17 receptor signaling in oral epithelial cells is critical for protection against oropharyngeal candidiasis","volume":"20","author":"Conti","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0710","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1128\/IAI.01389-13","article-title":"Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis","volume":"82","author":"Ferreira","year":"2014","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0715","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1084\/jem.20081463","article-title":"Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis","volume":"206","author":"Conti","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0720","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4049\/jimmunol.1500909","article-title":"IL-17-mediated immunity to the opportunistic fungal pathogen candida albicans","volume":"195","author":"Conti","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0725","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"Eyerich","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.112122_b0730","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1084\/jem.20130877","article-title":"Oral-resident natural Th17 cells and \u03b3\u03b4 T cells control opportunistic candida albicans infections","volume":"211","author":"Conti","year":"2014","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0735","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/eji.201747209","article-title":"IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model","volume":"48","author":"Bichele","year":"2018","journal-title":"Eur. J. Immunol."},{"issue":"48","key":"10.1016\/j.intimp.2024.112122_b0740","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba0570","article-title":"Oral epithelial IL-22\/STAT3 signaling licenses IL-17-mediated immunity to oral mucosal candidiasis","volume":"5","author":"Aggor","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.intimp.2024.112122_b0745","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease, Lancet 335(8697) (1990) 1078-80.","DOI":"10.1016\/0140-6736(90)92643-V"},{"issue":"10","key":"10.1016\/j.intimp.2024.112122_b0750","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","article-title":"Prevalence of Beh\u00e7et's disease in Istanbul, Turkey","volume":"42","author":"Azizlerli","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.intimp.2024.112122_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105593","article-title":"Beh\u00e7et disease: from pathogenesis to novel therapeutic options","volume":"167","author":"Rodr\u00edguez-Carrio","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2024.112122_b0760","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et's disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0765","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1002\/jcp.27207","article-title":"Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2024.112122_b0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2021.04.008","article-title":"Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease","volume":"235","author":"Gelmez","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2024.112122_b0775","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaut.2018.09.002","article-title":"Efficacy of the anti-IL 17 secukinumab in refractory Beh\u00e7et's syndrome: a preliminary study","volume":"97","author":"Di Scala","year":"2019","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.intimp.2024.112122_b0780","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08820139.2017.1288240","article-title":"natural killer cell subsets and their functional activity in Beh\u00e7et's disease","volume":"46","author":"Cosan","year":"2017","journal-title":"Immunol. Invest."},{"issue":"6 Suppl 94","key":"10.1016\/j.intimp.2024.112122_b0785","first-page":"S24","article-title":"Natural killer cells dominate a Th-1 polarized response in Beh\u00e7et's disease patients with uveitis","volume":"33","author":"Kucuksezer","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0790","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/cei.12939","article-title":"Circulating NK cells and their subsets in Beh\u00e7et's disease","volume":"188","author":"Hasan","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.112122_b0795","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/odi.13937","article-title":"Critical appraisal of different triggering pathways for the pathobiology of pemphigus vulgaris-a review","volume":"28","author":"Ramani","year":"2022","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0800","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI119130","article-title":"Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris","volume":"99","author":"Lin","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0805","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaci.2009.11.020","article-title":"Natural killer cells in atopic and autoimmune diseases of the skin","volume":"125","author":"von Bubnoff","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112122_b0810","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.jid.5700527","article-title":"T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris","volume":"127","author":"Takahashi","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112122_b0815","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2249.2008.03638.x","article-title":"Possible role of natural killer cells in pemphigus vulgaris - preliminary observations","volume":"152","author":"Stern","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.intimp.2024.112122_b0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109921","article-title":"The dysregulation of circulating innate lymphoid cells is related to autoantibodies in pemphigus vulgaris","volume":"117","author":"Zhu","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112122_b0825","doi-asserted-by":"crossref","first-page":"e14605","DOI":"10.1111\/dth.14605","article-title":"Does interleukin-33 level correlate with the activity of pemphigus vulgaris?: a case-control study","volume":"34","author":"Bakr","year":"2021","journal-title":"Dermatol. Ther."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924006404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T20:09:57Z","timestamp":1715630997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924006404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":165,"alternative-id":["S1567576924006404"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112122","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of innate lymphoid cells in oral diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112122"}}